A damning internal review has revealed that senior management at Ryhov County Hospital in Jönköping ignored repeated, documented warnings about a cardiologist whose clinical misjudgements may have endangered the lives of children — yet he was permitted to continue practicing for nearly a decade. The case, now under formal investigation by the Swedish Healthcare Inspectorate (IVO), exposes profound failures in clinical governance, risk management, and accountability — with implications extending far beyond healthcare into corporate oversight and public trust.
Early Warnings Ignored for a Decade
According to official statements confirmed by Maria Ekelund, Deputy Operations Manager at Ryhov between 2014 and 2018, the cardiologist — now employed by Region Skåne — was flagged for serious professional misconduct before his hiring in 2014. Two UK hospitals where he had previously worked raised formal concerns regarding his clinical judgment, documentation practices, and failure to consult specialists on high-risk cases.
Despite these red flags, the hospital proceeded with his recruitment. Over the following four years, at least five additional internal warnings were issued by colleagues and supervisors, including:
- 78 children incorrectly declared healthy during cardiac screenings, potentially delaying life-saving interventions;
- Inaccurate medication dosing in paediatric patients;
- Systematic failure to document critical clinical decisions;
- Refusal to escalate complex cases to multidisciplinary teams;
- Repeated non-compliance with hospital protocols.
These were not isolated incidents but patterns of behaviour documented in internal reports, emails, and peer reviews — all of which were dismissed or downplayed by leadership.
Resignation Over Patient Safety: A Chief Physician’s Plea
John Terlinder, then Chief Physician for Paediatric Cardiology at Ryhov, resigned in 2018 after exhausting all internal channels to halt the doctor’s clinical activities. His resignation letter, later obtained by Dagens Nyheter, stated unequivocally: “I was afraid that otherwise children would end up dying.”
Terlinder’s actions represent a rare public stance by a senior clinician who prioritized patient safety over institutional loyalty — a stance that, tragically, was met with institutional inertia. “We had the data. We had the warnings. We had the moral duty,” Terlinder told DN. “When leadership chooses silence over action, it becomes complicit.”
Leadership’s Response: Denial and Delay
Maria Ekelund, now a senior administrator elsewhere, acknowledged in a written statement to DN: “I am deeply sorry if children were assessed incorrectly, and if my former colleagues felt I did not listen.” Yet she maintained: “I did not perceive the doctor as a patient safety risk at the time; if he had been, we would have acted and reported this.”
This defense is legally and ethically untenable. Under Swedish healthcare law (SFS 2017:30), hospital management has a duty of care to act on credible, documented concerns about clinical competence — especially when they involve paediatric populations. The fact that multiple warnings were received, logged, and ignored constitutes a clear breach of this statutory obligation.
The doctor, whose name has not been publicly disclosed pending IVO’s investigation, currently holds a non-clinical administrative role at Region Skåne and has had no patient contact since September 2024, when the case first surfaced publicly. He has not responded to multiple requests for comment from SVT.
Simon Rundqvist, current Operations Manager at Ryhov, has declined to comment until further investigation concludes. His office has not provided any statement on whether internal review procedures have been revised, or whether accountability measures have been implemented.
Corporate Governance Lessons: When “We Didn’t Know” Is Not an Excuse
This case is not merely a clinical failure — it is a corporate governance failure. The same patterns of ignored warnings, delayed escalation, and leadership denial are seen in corporate scandals from Enron to Wirecard. In healthcare, the stakes are human lives.
Key takeaways for Nordic business leaders and public sector executives:
- Early Warning Systems Must Be Actionable — Documented concerns from credible sources (e.g., international employers, peer reviews) must trigger immediate risk assessments, not bureaucratic delays.
- Whistleblower Protection Is Non-Negotiable — Dr. Terlinder’s resignation was a last resort. Institutions must create safe, anonymous channels for staff to report concerns without fear of retaliation.
- Compliance ≠ Safety — Following routine protocols is insufficient if those protocols are being circumvented by individuals with known deficits. Proactive risk monitoring is required.
- Leadership Accountability Must Be Institutionalized — No executive should be shielded by claims of “not knowing.” In the age of digital records and audit trails, ignorance is a choice — and a liability.
Parallel Issue: Illegal Marketing of Weight-Loss Drugs
n a separate but equally concerning development, Swedish regulators are investigating a surge in social media marketing of prescription weight-loss medications — including semaglutide (Ozempic, Wegovy) and tirzepatide (Mounjaro) — by private clinics and influencers.
Claes Granmar, Associate Professor of European Law at Stockholm University, confirms this violates both the Swedish Medicines Act (Läkemedelslagen) and the Swedish Medical Association’s ethical guidelines, which strictly prohibit direct-to-consumer advertising of prescription drugs — except for vaccines.
Marketing prescription drugs on Instagram or TikTok is not just unethical — it’s criminal,” Granmar stated. “These are not cosmetics. These are potent pharmaceuticals with documented risks: pancreatitis, gallbladder disease, and potential psychiatric side effects. Companies are exploiting regulatory gaps and consumer desperation. The Swedish Medical Products Agency must act — and prosecute.”
Conclusion: A System That Failed Children — And Must Be Fixed
The Ryhov case is a stark reminder that in high-stakes sectors — healthcare, finance, aviation — organizational culture can be the most dangerous risk factor. When leadership prioritizes reputation over responsibility, and process over people, systemic collapse becomes inevitable.
Region Jönköping and Region Skåne must now:
– Publicly release the full IVO report;
– Implement mandatory third-party governance audits;
– Establish an independent patient safety ombudsman;
– Disclose whether any disciplinary or legal actions have been taken against managers who ignored warnings.
The children who were misdiagnosed cannot be restored. But the institutions that failed them can still be held accountable — and reformed.
For Nordic business leaders: This is not a healthcare story. It is a leadership story. And it is a warning.
This article was updated on November 17, 2025, to reflect the latest developments, including the doctor’s current non-clinical status and the legal analysis of social media drug marketing. The Swedish Healthcare Inspectorate (IVO) is expected to release its preliminary findings by December 2025.
The Nordic Business Journal will continue to monitor this case and publish follow-up analyses on institutional accountability frameworks in public sector management.